A Brief Intervention for Cannabis Use

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Apr 29, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at ways to help young adults, aged 18 to 25, who may be using cannabis in a way that could be harmful to their health. The study will compare two short treatment sessions, each lasting about 40-50 minutes, to see which one is more effective in supporting these individuals. Participants will first go through a detailed assessment of their cannabis use, including some tests, and then they will randomly be assigned to one of the two treatment sessions. After the sessions, there will be follow-up assessments to check on their progress at one month and three months later.

To join the study, participants need to be between 18 and 25 years old and have used cannabis on at least 20 days in the past month. They must also have tested positive for cannabis during an initial visit. However, people who are currently receiving treatment for substance use disorders or have serious medical or mental health issues cannot participate. Throughout the trial, participants will provide saliva samples to measure levels of cannabis compounds in their system, which will help researchers understand the effects of the interventions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Ages 18-25
• • Self-Report report cannabis use on at least 20 days of the past 30 days.
• • Completion of an Intake Visit (PRO #94743)
• • Submit a positive urine cannabinoid test during the Intake Visit
• Exclusion Criteria:
• • Currently engaged in substance use treatment for any type of substance use or currently treatment seeking
• • History of substance use treatment for any type of substance
• • Severe alcohol use disorder or presence of any substance use disorder (SUD) requiring a higher level of care
• • Significant or acutely unstable medical or psychiatric problems (i.e., psychosis, mania) that would contraindicate research procedures, interfere with safety, compromise data integrity, or preclude consistent study participation
• • Significant risk of suicide or homicide